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Abstract (200 words) 28 
 29 
 30 
Studying circadian rhythms in most human tissues is hampered by difficulty in collecting serial 31 
samples. Here we reveal circadian rhythms in the transcriptome and metabolic pathways of human 32 
white adipose tissue. Subcutaneous adipose tissue was taken from seven healthy males under highly 33 
controlled ‘constant routine’ conditions. Five biopsies per participant were taken at six-hourly 34 
intervals for microarray analysis and in silico integrative metabolic modelling. We identified 837 35 
transcripts exhibiting circadian expression profiles (2% of 41619 transcript targeting probes on the 36 
array), with clear separation of transcripts peaking in the morning (258 probes) and evening (579 37 
probes). There was only partial overlap of our rhythmic transcripts with published animal adipose 38 
and human blood transcriptome data. Morning-peaking transcripts associated with regulation of 39 
gene expression, nitrogen compound metabolism, and nucleic acid biology; evening-peaking 40 
transcripts associated with organic acid metabolism, cofactor metabolism and redox activity. In silico 41 
pathway analysis further indicated circadian regulation of lipid and nucleic acid metabolism; it also 42 
predicted circadian variation in key metabolic pathways such as the citric acid cycle and branched 43 
chain amino acid degradation. In summary, in vivo circadian rhythms exist in multiple adipose 44 
metabolic pathways, including those involved in lipid metabolism, and core aspects of cellular 45 
biochemistry.  46 
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Introduction 47 
 48 
 49 
Many aspects of mammalian metabolism exhibit daily variation driven in part by an endogenous 50 
circadian timing system 1. This system is comprised of a central ‘master’ clock in the hypothalamic 51 
suprachiasmatic nuclei and an integrated network of circadian clocks present in all major tissues 52 
within the body 2. Circadian disruption causes abnormal metabolic physiology 3. Misalignment of 53 
human clocks with each other and the environment is believed to be a major contributor to obesity 54 
and related pathologies associated with shift work 4,5. 55 
 56 
At the molecular level, circadian clocks are formed from a set of inter-locking transcriptional 57 
translational feedback loops (TTFLs). In the core TTFL, transcription factors CLOCK and ARNTL (also 58 
known as BMAL1) stimulate transcription of three Period (Per) and two Cryptochrome (Cry) genes. 59 
Once translated the PER and CRY proteins bind to one another, translocate to the nucleus and inhibit 60 
the transcriptional activity of CLOCK and BMAL1, eventually repressing their own transcription 6. A 61 
key secondary loop involves rhythmic transcription of Rev-erbα (Nr1d1) by the CLOCK-BMAL1 62 
complex. The resulting rhythmic accumulation of REVERBα protein provides temporal inhibition of 63 
Bmal1 transcription and thus feeds back onto the core TTFL 7. In addition to defining internal 64 
biological time, clock proteins also bind to response elements in output genes 8,9. Many of these 65 
output genes themselves encode transcription factors and thus the circadian clock can temporally 66 
regulate a large part of the transcriptome 10,11. 67 
 68 
It is estimated that nearly half of all murine genes exhibit a circadian expression profile in at least 69 
one tissue of the body 10. Many of the rhythmic genes in a tissue are integral to local physiological 70 
function. Despite advances in understanding of circadian rhythmicity in animal tissues, there is very 71 
little information on molecular rhythms in humans. Transcriptomic analyses of human whole blood 72 
suggest that approximately 7-9% of genes in whole blood RNA are rhythmic 12,13, a similar proportion 73 
to that found within individual mouse tissues. However, it is difficult to access other human tissues 74 
for serial sampling. We and others have recently developed biopsy protocols for serial tissue 75 
collection of human skeletal muscle and subcutaneous white adipose tissue over 24-hours 14-16. Here 76 
we have combined our adipose tissue biopsy method with the gold standard 'constant routine' 77 
protocol 17 to study the circadian transcriptome in human adipose tissue. The constant routine 78 
protocol removes rhythmic changes in environmental factors and behaviours (including light-dark, 79 
sleep-wake and feed-fast cycles) that are known to influence human circadian rhythms 13,18. 80 
Resulting rhythms are therefore driven primarily by the endogenous circadian system. 81 
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Results  82 
 83 
In this study seven healthy male participants underwent restricted sleep-wake and meal times 84 
before entering the laboratory, to maximise circadian synchronisation. They maintained this sleep 85 
and feeding schedule for three days in the laboratory before undergoing a 37-hour constant routine, 86 
during which five six-hourly subcutaneous adipose tissue biopsies were taken per participant. 87 
Transcriptomic data were generated from these biopsies and then subjected to in-depth 88 
bioinformatic analysis. 89 
 90 
 91 
Circadian expression of the human adipose transcriptome 92 
 93 
Genes were classified as circadian if the expression profile(s) of one or more of their associated 94 
transcripts exhibited one full oscillation every 24 hours. To identify the set of genes with circadian 95 
profiles we fitted a sinusoidal function to the data, set a threshold to the R2 value of the fit and 96 
restricted the amplitude’s 95% CI to not include zero. Using these criteria, we identified circadian 97 
rhythms in 837 transcripts (~ 2% of all transcript targeting probes). Unsupervised clustering 98 
performed on the 837 circadian transcripts revealed 3 distinct clusters (Fig. 1A). Two of these 99 
clusters (yellow, 233 transcripts; light green, 346 transcripts) had peak expression in the circadian 100 
evening, whereas the third cluster (dark green, 258 transcripts) had peak expression in the circadian 101 
morning (Fig. 1B). Furthermore, a frequency plot of the peak time of each rhythmic transcript 102 
revealed a bimodal distribution, with peaks predominantly occurring in the evening and morning 103 
(Fig. 1C). For subsequent analysis, yellow and light green clusters were pooled together to form a set 104 
of 579 'evening' transcripts, whereas the dark green cluster provided the 258 'morning' transcripts. 105 
Example transcript profiles for morning and evening-peaking genes are presented in Fig. 1D and 1E, 106 
respectively. A full list of all circadian transcripts is provided in Supplementary Table S1. The 837 107 
transcripts are associated with 727 unique genes, on which we focus our interpretation. 108 
 109 
 110 
Function of circadian genes in the human adipose transcriptome 111 
 112 
Canonical clock genes exhibited robust rhythmicity in biopsies taken under constant routine 113 
conditions. Seven core clock genes were found to be rhythmic. Two clock genes (ARNTL, NPAS2) 114 
peaked in the circadian evening; the other clock genes (PER1, PER2, PER3, CRY2, NR1D1) peaked in 115 
the circadian morning (Fig. 2). 116 
 117 
Validated databases were interrogated using our 727 circadian genes to identify rhythmic biological 118 
functions. GO enrichment analysis revealed a temporal separation of biological processes associated 119 
with circadian genes (Table 1). Most of the processes associated with the evening peaking 120 
transcripts were aspects of metabolism, including organic acid, co-factor and oxidation-reduction. 121 
Morning peaking genes were significantly associated with gene expression regulation, nucleic acid 122 
regulation and other metabolic processes. Further GO molecular function enrichment analysis 123 
indicated a predominance of nucleic acid and transcription factor binding in the morning, whereas 124 
catalytic and reductase activity was enhanced in the evening (Table 2). 125 
 126 
 127 
Comparison with the adipose circadian/diurnal transcriptome in non-human species 128 
 129 
In a previous study of mouse white adipose tissue, 856 genes (~ 4% of genes assessed) were 130 
identified as having circadian rhythmicity 10. Of those, only 32 transcripts were also classified as 131 
rhythmic in our human data set (Supplementary Table S2): 19 peaked in the evening and included 132 
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the positive arm canonical clock genes, Bmal1 and Npas2, whilst the remaining 13 peaked in the 133 
morning. Phases within the mouse data were expressed relative to circadian time (CT). The 134 
acrophases of most of these genes occurred at similar times within the behavioural cycle of diurnal 135 
humans and nocturnal mice. For example, PER3 in our human data peaks at 8.8 hours after the dim 136 
light melatonin onset (DLMO), which is near the time of awakening, whilst in the mouse white 137 
adipose tissue data Per3 peaked at CT12, which is defined as the onset of activity in constant 138 
darkness (i.e. biological evening for a nocturnal rodent). Similarly, the antiphasic gene ARNTL 139 
(BMAL1) in humans had an acrophase of -0.9 hours relative to the DLMO, which equates to 140 
biological evening, whilst in mouse white adipose tissue it peaked at CT23 which approximates to 141 
the onset of the main rest phase (biological morning in a nocturnal rodent). A summary of the 142 
phases is presented in Supplementary Table S2. 143 
 144 
We also compared the circadian rhythmic genes from our data set with genes expressed in baboon 145 
white adipose tissue that have recently been reported to have diurnal rhythmicity, i.e. 24-hour 146 
rhythms when experimental subjects are in an entrained rhythmic environment 19. Only 14 genes 147 
were rhythmic in both human and baboon adipose data sets: CRY2, PER1, PER2, NPAS2, ARNTL, 148 
NR1D1, ZDHHC14, SCN3B, PCYT2, TMEM8A, GNA12, P4HA2, C3orf31 (TAMM41) and RASL10B. 149 
 150 
Because of the limited overlap in rhythmic genes between the human and mouse and baboon 151 
tissues, we also investigated the overlap in GO biological processes associated with the human 152 
adipose rhythmic genes, which could potentially show higher levels of similarity. GO annotation for 153 
all three genomes (human, mouse, and baboon) was downloaded from the Gene Ontology database 154 
(https://www.ebi.ac.uk/GOA/ on 13 October 2018). From these annotations the GO terms 155 
associated with biological processes were retained. Rhythmic genes that are homologous to (or 156 
present in) human were annotated using the respective GO biological process annotation. Overlaps 157 
in the identifiers of the GO terms was then assessed. The results of this analysis are shown in the 158 
Venn diagram of Fig. 3. The mouse has the largest number of associated GO terms and the baboon 159 
the least, and these differences presumably reflect differences in the depths of annotation for each 160 
species. However, greater levels of overlap are now apparent with 27% of human biological 161 
processes overlapping with 46% of the baboon processes, and 59% of human biological processes 162 
overlapping with 35% of the mouse processes. Four hundred and thirty-six terms were common to 163 
each species, which represents 23%, 39% and 14% of the human, baboon and mouse total biological 164 
processes, respectively. Supplementary Table S3 shows the top ten biological processes for the 165 
human vs. baboon, human vs. mouse and all three species comparisons that have been ranked 166 
according to the frequency of occurrence of the human biological processes. 167 
 168 
Comparison with the human whole-blood transcriptome 169 
 170 
To assess the similarity of circadian transcriptomes in different human tissues, we compared the 171 
current data from human white adipose tissue with published data sets from human whole-blood 172 
samples. Specifically, we used data from the constant routine following a week of sufficient sleep in 173 
a sleep restriction study 12 and the baseline condition of a forced desynchrony study where sleep 174 
occurred in phase with melatonin 13. Comparison of the datasets identified a larger overlap between 175 
circadian transcriptomes of the adipose tissue and blood samples taken in constant routine, than 176 
adipose tissue and blood taken from the baseline period of the forced desynchrony study. In total, 177 
14 genes were circadian in both blood data sets and in human subcutaneous adipose tissue 178 
(Supplementary Dataset 1). These genes included the canonical clock genes, ARNTL (BMAL1), NPAS2, 179 
PER2, PER3, together with NR1D2 (REVERB-β), ribosome biogenesis factor (BMS1), C-type lectin 180 
domain family 18 member b (CLEC18B), clusterin associated protein 1 (CLUAP1), coactosin-like F-181 
actin binding protein 1 (COTL1), histone cluster 2 H2B family member E (HIST2H2BE), myelin protein 182 
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zero-like 1 (MPZL1), poly(A) binding protein interacting protein 2B (PAIP2B) and ribosomal protein 183 
large subunit 22 (RPL22). 184 
 185 
 186 
Interaction network analysis 187 
 188 
In addition to the GO enrichment analyses, predicted molecular interactions related to the 727 189 
circadian genes were assessed using the online STRING tool. Predicted interactions derived from the 190 
morning-peaking genes were limited (Fig. 4). The main cluster within the network was associated 191 
with the circadian clock. However, small interaction networks were also observed for mRNA 192 
processing/splicing (e.g. Cleavage and polyadenylation specificity factor subunit 1, CPSF1; 193 
Heterogeneous nuclear ribonucleoprotein A3, HNRNPA3; Splicing factor 45/RNA-binding motif 194 
protein 17, RBM17), cell cycle/centrosome regulation (e.g. Cyclin-dependent kinase 11A, CDK11A; 195 
Pericentriolar material 1 protein, PCM1; Pericentrin, PCNT), and oxido-reductase/dehydrogenase 196 
activity (e.g. Acyl-CoA oxidase 3, pristanoyl, ACOX3; Acyl-CoA synthetase short chain family member 197 
1, ACSS1; Aldehyde dehydrogenase 9 family member A1, ALDH9A1; Dehydrogenase/reductase 1, 198 
DHRS1; Hexose-6-phosphate dehydrogenase, H6PD). 199 
 200 
A much larger set of interactions was generated from analysis of the evening-peaking genes 201 
(Supplementary Fig. S1). Within this network, many of the molecules with the largest number of 202 
interactions were involved in fatty acid, amino acid and carbohydrate metabolism. These included: 203 
Short-chain specific acyl-CoA dehydrogenase (SCAD, from the ACADS gene), Aldehyde 204 
dehydrogenase family 1 member B1 (ALDH1B1), Citrate synthase (CS), Dihydrolipoyllysine-residue 205 
acetyltransferase component of pyruvate dehydrogenase complex (DLAT), 3-hydroxyisobutyryl-CoA 206 
hydrolase (HIBCH), Malate dehydrogenase (MDH2), and Serine hydroxymethyltransferase (SHMT1). 207 
 208 
The network generated from the evening-peaking genes also included some smaller clusters. These 209 
included clusters relating to glutathione metabolism (Glutathione S-transferase Mu 1, GSTM1; 210 
GSTM3; GTSM4; GTSM5; Glutathione peroxidase 8, GPX8), protein ubiquitination (Ankyrin repeat 211 
and SOCS box protein 8, ASB8; F-box only protein 15, FBXO15; Leucine-rich repeat protein 1, LRR1; 212 
TNF receptor-associated factor 7, TRAF7; Ubiquitin-conjugating enzyme E2 L3, UBE2L3), protein 213 
trafficking and Golgi function (ADP-ribosylation factor 1, ARF1; ARF4; BET1-like protein, BET1L; 214 
Coatomer subunit gamma-2, COPG2; Dynein light chain 1, DYNLL1; DYNLL2; KDEL endoplasmic 215 
reticulum protein retention receptor 2; KDEL2; Kinesin-1 heavy chain, KIF5B; Surfeit locus protein 4, 216 
SURF4). 217 
 218 
 219 
Metabolic network analysis  220 
 221 
To predict circadian variation in metabolic reactions and associated pathways, our transcriptome 222 
data were applied to comprehensive pre-existing models of human metabolism. Consistent with our 223 
GO analysis, circadian rhythms were closely associated with fatty acid metabolism. Multiple 224 
reactions in mitochondrial fatty acid elongation (Fig. 5), biosynthesis and degradation pathways 225 
were predicted to exhibit circadian variation. 226 
 227 
Analyses also predicted circadian variation in multiple steps of other key cellular metabolic pathways 228 
including: purine and pyrimidine metabolism; the citric acid cycle, the pentose phosphate pathway, 229 
branched chain amino acid degradation pathways and glycosylphosphatidylinositol (GPI) anchor 230 
biosynthesis. The full list of reactions and metabolic pathways that display change in activity can be 231 
found in Supplementary Dataset 2 (rhythmic reactions identified by R2 ≥ 0.8).  232 
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Discussion 233 
 234 
This study contains the first 24-hour transcriptomic profiling of human adipose tissue in samples 235 
collected during a protocol that permits expression of endogenous circadian rhythms in vivo. 236 
Unmasking of circadian rhythms in a constant routine protocol permits removal/minimisation of 237 
rhythmic changes in the environment, feeding behaviour and sleep-wake physiology, which are 238 
known to influence 24-hour rhythms 17,18. Our previous report of temporal gene expression in the 239 
same depot of human adipose tissue 14 assessed daily variation of clock gene expression in entrained 240 
(‘diurnal’) conditions. Nonetheless the phase of canonical clock gene expression is highly conserved 241 
between our two studies. Our previously reported diurnal rhythms described a peak of 242 
BMAL1/ARNTL expression in the late evening with PERs, CRY2, and REVERBα/NR1D1 peaking around 243 
late morning 14. In the current study, BMAL1/ARNTL exhibited peak expression in the late biological 244 
evening, with the other clock genes peaking in mid-late biological morning. Our data add to existing 245 
knowledge of adipose rhythms 20 and indicate that robust circadian rhythmicity exists in human 246 
adipose tissue in vivo and is associated with fundamental metabolic processes. 247 
 248 
Assessment of rhythmicity in the transcriptome was performed using methods that allow the 249 
characterization of an expression profile based on its phase, amplitude and period, similar to the 250 
methods previously used for analysis of the circadian transcriptome in human whole blood 12,13. The 251 
estimate that ≈ 2% of the adipose transcriptome exhibits circadian rhythms is lower than the value 252 
estimated in previous studies, as reviewed elsewhere 11 but still represents many hundreds of 253 
circadian genes. The lower estimate of circadian gene prevalence may be a feature of the tissue but 254 
may also reflect protocol design, technological platforms, and the analytical algorithms used to 255 
identify rhythmic signals, as discussed previously 11. The cohort size and sampling resolution within 256 
our study is also lower than that recently recommended for genome-wide circadian analysis 21, but is 257 
a necessary ethical and practical limitation when taking serial human biopsies. Our circadian genes 258 
separated into two clearly defined groups with a bimodal distribution of peak expression. A similar 259 
bimodal distribution has been reported in the circadian transcriptome of human blood 12,13 and 260 
diurnal transcriptome of human skeletal muscle 16 indicating that it is a common feature of 24-hour 261 
organisation of molecular processes in humans. 262 
 263 
The results of our transcriptome analysis were first interpreted using Gene Ontology (GO) 264 
enrichment analysis. Biological processes in GO annotation highlight the overall biological purpose of 265 
a gene’s product whilst molecular function relates to the specific function of a gene product 22. For 266 
the morning-peaking genes, GO enrichment revealed processes relating to circadian rhythms, as 267 
most of the clock genes had peak expression in the morning. In addition, GO analysis revealed 268 
prominent roles of morning-peaking genes related to gene expression (e.g. transcription factor and 269 
nucleic acid binding; histone deacetylation) and metabolism of nitrogen-containing compounds. A 270 
study examining the subcutaneous human adipose tissue transcriptome in biopsies taken over a 12-271 
hour period also found that the function of morning genes was enriched for transcription and 272 
translation 23. Evening-peaking genes saw GO enrichment in multiple metabolic processes including 273 
organic acid metabolism. Enriched molecular functions included oxidoreductase activity and lytic 274 
activity. Consistent with this finding, mouse white adipose rhythms are closely involved in lipolysis 24 275 
indicating a conserved circadian involvement in catalytic functions. 276 
 277 
Comparison of our data with published circadian transcriptome datasets yielded a relatively small 278 
number of common circadian genes. Notwithstanding the core clock genes, circadian transcriptome 279 
data are typically specific to the relevant tissue(s) in question 10,11. Comparing circadian genes in 280 
human adipose tissue from the current study with those in human blood is potentially complicated 281 
by the fact that our study only involved male participants, whereas the studies of human blood 282 
included mixed male and female participants. Nonetheless, the non-clock genes common to all three 283 
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studies were BMS1, CLEC18B, CLUAP1, COTL1, MPZL1, PAIP2B and RPL22. Products of these genes 284 
have very different functions: BMS1 is a likely ribosome biogenesis factor (by similarity), CLEC18B 285 
binds polysaccharides 25, CLUAP1 functions in cilia biogenesis and hedgehog signalling 26, COTL1 286 
helps to regulate the actin skeleton 27, MPZL1 is involved in signal transduction 28, whereas PAIP2B 287 
and RPL22 are involved in translation 29,30. Circadian genes that were common to human adipose 288 
tissue and at least one of the blood datasets were involved in fundamental processes for cell 289 
function; namely circadian rhythm regulation, metabolic processes and transcription and translation. 290 
 291 
The low overlap between circadian transcriptomes in human and mouse adipose tissue could derive 292 
from species differences as well as different physiological properties of the adipose depots 31. In 293 
addition to the clock genes, conserved rhythmicity was observed in Cpsf1, Gstt2, Hlf, Rev1, Plce1, 294 
Nqo2, Rev1 and Timm10. These genes have roles like those seen in the GO biological enrichment. 295 
CPSF1 is involved in processing the 3’ end of pre-mRNA 32; HLF is a transcription factor 33; GSTT2 296 
catalyses glutathione conjugation to both hydrophilic and hydrophobic compounds 34; and REV1 is 297 
involved in DNA polymerase-mediated repair of DNA 35. Similarly, genes in both adipose depots were 298 
involved with metabolism; PLCE1 catalyses PIP2 into secondary messenger molecules IP3 and DAG 36; 299 
NQO2 reduces quinone substrates 37 and TIMM10 inserts hydrophobic proteins into the 300 
mitochondrial inner membrane 38. 301 
 302 
We finally assessed the functional consequence of our transcriptomic data through molecular 303 
interactions and metabolic pathway activity. The inferred/known molecular interaction networks 304 
supported the GO findings, highlighting networks involved in circadian rhythms and key aspects of 305 
cellular metabolism. In addition, STRING analysis revealed clusters regulating other core aspects of 306 
cell biochemistry, such as mRNA processing/splicing, protein trafficking and Golgi function. 307 
Application of our transcriptomic data to human metabolic network models further supported key 308 
roles of adipose circadian rhythms in: fatty acid metabolism; nucleic acid metabolism; and other 309 
fundamental aspects of cell function, such as the citric acid cycle. These novel findings indicate the 310 
association of circadian processes with specific and critical metabolic pathways in cellular 311 
metabolism of human white adipose tissue. 312 
 313 
Our study has some limitations. As noted above, we only studied male participants. Previous 314 
research has demonstrated gender differences in circadian rhythmicity 39,40 and white adipose 315 
physiology varies between men and women 41. It will therefore be important to compare rhythms in 316 
a wider population in future work. The sample size reported in this manuscript is quite small, 317 
although comparable to many controlled laboratory human studies of this nature. Sample size is 318 
limited by the cost and ethical considerations of running such complex human studies. However, it 319 
must be emphasised that an important advantage of our study is that we were able to obtain 320 
repeated samples from each participant. 321 
 322 
 323 
Conclusions 324 
 325 
Molecular analysis of serial adipose tissue biopsies, taken under highly controlled conditions and 326 
coupled with in-depth bioinformatic analysis, has revealed the importance of circadian biology on a 327 
key human metabolic tissue. The most common rhythmic processes in human subcutaneous white 328 
adipose are those linked to fatty acid metabolism. However, rhythmicity was also observed in other 329 
fundamental cell processes, e.g. transcription and translation, nucleic acid metabolism and the citric 330 
acid cycle. The circadian timing system thus has an intimate relationship with many core aspects of 331 
human physiology and pathways relevant to therapeutics. 332 
 333 
  334 
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Methods 335 
 336 
 337 
Participants 338 
 339 
The study received a favourable ethical opinion from the University of Surrey Ethics Committee and 340 
was conducted in accordance with the guidelines laid down in the Declaration of Helsinki. Written, 341 
informed consent was obtained prior to any study procedures being performed. We recruited seven 342 
participants, who were male, aged 18-30 years with body mass index (BMI) ≥ 19kg/m2 and ≤ 343 
30kg/m2 and fat mass > 14%. These participants were part of a cohort recruited for a previously 344 
published study 18. They had no medical history that indicated a sleep or metabolic disorder and had 345 
not undertaken shift work within six months or crossed more than two time zones within one month 346 
of the study. Participants (Table 3) completed a set of validated sleep and chronotype questionnaires 347 
and were required to meet the following inclusion criteria: Pittsburgh Sleep Quality Index (score ≤ 5), 348 
Epworth Sleepiness Scale (score < 10), Horne-Östberg diurnal preference questionnaire (score 349 
between but not including 30-70, indicating that they are not extreme morning or evening types). 350 
Their habitual bed time was between 22:00 and 01:00 and wake time between 06:00-09:00 for 5 351 
nights a week; habitual sleep duration was 7-9 hours per night. 352 
 353 
All participants were medically assessed (electrocardiogram, blood pressure, heart rate, oral 354 
temperature and respiration rate) at the Surrey Clinical Research Centre (CRC) as part of a screening 355 
visit. They were required to test negative for drugs of abuse such as opiates, alcohol and cotinine, a 356 
metabolite of nicotine. A full blood biochemistry screen was conducted to ensure good health and 357 
medication records were reviewed. 358 
 359 
 360 
Study design 361 
 362 
Ten days prior to the study session, participants were instructed to select and maintain a bed time 363 
(between 22:00 and 01:00) and wake time (between 06:00 and 09:00) that closely matched their 364 
habitual sleep-wake time, with a time-in-bed duration of at least 8 hours. If required, a nap was 365 
allowed within a 4-hour window, with the middle of the nap window being 12 hours after the 366 
midpoint of sleep. Additionally, participants were required to obtain 15 minutes of unobstructed 367 
natural light exposure within 1.5 hours of wake. Compliance was monitored using two L-actiwatches 368 
(Cambridge Neurotechnology Ltd, Cambridge, UK). One actiwatch was worn on the non-dominant 369 
wrist for activity analysis, whereas the other was worn around the neck for analysis of light 370 
exposure. Participants maintained a sleep diary and called a time-stamped voice mail within 10 371 
minutes of the selected bed and wake times. 372 
 373 
Seven days prior to the study, participants were asked to restrict the time they ate their meals to the 374 
following: breakfast 30 minutes after wake, lunch 5.5 hours after wake and dinner 10.5 hours after 375 
wake. Caffeine was restricted to no more than 100 mg in the first three hours of waking, and a 376 
maximum of 4-5 units of alcohol was allowed per day. Seventy-two hours prior to the laboratory 377 
study, participants were given food by the study team to resemble the food they would consume 378 
during the study. They were required to maintain the meal schedule detailed above and, in addition, 379 
they were not allowed to consume any caffeine or alcohol and were asked to refrain from any heavy 380 
exercise during those 72-hours. 381 
 382 
Participants entered the Surrey CRC, received a standard meal and went to bed in individual sleep 383 
rooms at the same time as they had selected during the pre-study protocol. Over the next 3 days, 384 
participants continued their same sleep-wake and meal schedule. All meals were isocaloric with the 385 
10 
 
same macronutrient content (55% carbohydrate, 15% protein and 30% fat) and eaten in individual 386 
rooms. Meals were calorie adjusted to meet the individual energy requirements of the participant 387 
using the Schofield equation 42. Participants could move around when not eating, but no strenuous 388 
activity was allowed. Over laboratory days 4 and 5, participants underwent a 37-hour constant 389 
routine. Sampling during the constant routine began five hours into the constant conditions to 390 
eliminate any run-in effects and consisted of hourly blood sampling and five six-hourly subcutaneous 391 
adipose tissue biopsies from the upper gluteal region, which is known to be metabolically active 43. 392 
Biopsy tissue (≈200 mg per biopsy) was snap frozen in liquid nitrogen and stored at -80oC until RNA 393 
extraction. Blood was collected into tubes containing lithium heparin anticoagulant, inverted 10 394 
times, cooled, and centrifuged (1,620 g, 10 mins, 4°C) within 30 minutes of collection. Plasma was 395 
then collected and stored at -20°C ready for analysis. 396 
 397 
 398 
Plasma melatonin analysis 399 
 400 
All plasma melatonin determinations were conducted by Stockgrand Ltd (University of Surrey) using 401 
a tritium-based assay described elsewhere 44. Dim light melatonin onset (DLMO) was calculated 402 
using the 25% method to permit alignment of gene expression to an endogenous circadian phase 403 
marker 45. 404 
 405 
 406 
Microarray analysis of biopsy tissue 407 
 408 
RNAlater-ICE solution (Thermo Fisher Scientific) was pre-chilled at -80°C and 10 µl per mg of tissue 409 
was added to the frozen adipose tissue. The tissue was then kept for a minimum of 16 hours at -410 
20°C. RNA was extracted from approx 30 mg of the thawed adipose tissue using the RNeasy mini kit 411 
(Qiagen, Hilden, Germany) according to the manufacturer’s protocol. The RNA was then assessed for 412 
quantity and quality using the NanoDrop 2000 spectrophotometer (LabTech International) and 413 
Agilent 2100 Bioanalyzer (Agilent Technologies) with the RNA 6000 Nano Kit. Samples had an 414 
average RNA Integrity Number (RIN) of 7.3 ± 0.72 (mean ± SEM). RNA was labelled and amplified to 415 
produce cRNA using the one-colour low input quick amp labelling kit (Agilent Technologies). 416 
Hybridisation of cRNA to arrays (Agilent, human whole genome custom microarrays 4x44k as 417 
described in the Gene Expression Omnibus, GEO 46,47; platform ID: GPL15331) was performed for 17 418 
hours at 65°C following Agilent Technologies instructions. Once slides had been washed and scanned 419 
using an Agilent microarray scanner, data were extracted using Agilent Feature Extraction Software 420 
(Agilent [version 11.5.1.1]). 421 
 422 
Individual samples were filtered based on the AgilentQC metrics provided by Agilent Feature 423 
Extraction software. Only one sample was excluded based on our criteria that a sample should have 424 
a median coefficient of variation (CV) of less than 10% in spike-ins or in non-control replicated 425 
probes. For the remaining samples log2 mRNA abundance values were quantile-normalized across all 426 
arrays using the R Bioconductor package limma 48. Non-control replicated probes, along with their 427 
corresponding flags were averaged. Probes with more than 66% of samples flagged by Agilent FE 428 
software were not considered. The microarray dataset is accessible from GEO via accession number 429 
GSE87761. 430 
 431 
Circadian alignment of subjects was conducted by referencing each participant’s sampling times to 432 
the participant’s melatonin onset (DLMO value). A single component cosinor, with added linear 433 
trend and assuming 24 h period, was fitted to the mRNA abundance profile of each microarray probe 434 
by a linear mixed model with subjects as random effects using the lme4 package from R 49. A 435 
circadian oscillation was considered if the mixed model fit had an R2 value higher than 0.8 and the 436 
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95% confidence interval (CI) of the calculated amplitude did not include the zero value. The false 437 
discovery rate (FDR) was calculated as the expected proportion of the circadian probes that are 438 
classed as circadian after sample labels within each subject had been randomly permuted. A total of 439 
100 random permutations were done for each probe independently and FDR was < 10%. 440 
 441 
Note that most alternative methods for determining rhythmicity make assumptions that are not 442 
compatible with our data. They assume replicated time points and evenly sampling points, i.e. all 443 
data samples come from different participants, there are several measurements for the same time 444 
point and sampling is performed at regular, fixed intervals. Our dataset has replicated time-series 445 
instead of replicated time points. Each participant provided data for all time points and although the 446 
sampling interval is similar across participants, the sampling time points are unique as they are 447 
adjusted to each participant’s melatonin profile. 448 
 449 
Probes that had been identified as rhythmic underwent unsupervised clustering 12,13,50 using a 450 
circular self-organising map 50. Three clusters were identified as the optimal partition based on the 451 
Bayesian Information Criterion (BIC) 51. For further downstream analysis/interpretation, two of these 452 
three clusters exhibiting peak expression within 5-hours of DLMO were analysed together and 453 
defined as evening-peaking. The third cluster was defined as morning-peaking. 454 
 455 
Gene ontology (GO) enrichment analysis was conducted using Metacore software (Version 6.33, 456 
Build 69110). GO biological processes and molecular functions that had an enrichment p value and a 457 
corresponding FDR of less than 0.05 were considered to be significantly enriched 52. Molecular 458 
interactions were identified/predicted using the online search tool STRING (www.string-db.org; V 459 
10.5) 53. The gene symbols associated with each transcript belonging to a cluster were entered as a 460 
multiple protein search. Default settings were used to identify/predict interactions with a minimum 461 
interaction (confidence) score of 0.4, corresponding to medium level of confidence. 462 
 463 
 464 
Comparison of rhythmic genes with other circadian datasets 465 
 466 
Genes associated with circadian transcripts were compared to rhythmically expressed genes 467 
identified by transcriptome analyses of mouse organs 10, human whole blood 12,13 and Olive Baboon 468 
19. Ensembl Biomart 54 was used to identify homologous genes between organisms and cross-469 
referenced with the gene symbols reported by each of the transcriptome studies.  Expression 470 
profiles and peak times for rhythmic genes in mouse white adipose tissue were extracted from 471 
CircaDB 55. 472 
 473 
 474 
Metabolic network analysis 475 
 476 
To predict the activity of metabolic reactions within the human system the ‘Fast iMAT’ algorithm of 477 
MUFINS 56, a variant of the iMAT algorithm 57,58, was used. Under a constraint-based modelling 478 
framework, iMAT approaches aim to maximise the congruency between functional -omic data and 479 
the activity of metabolic reactions in a metabolic model. Here, for each of the five time points 480 
assessed, we conducted Fast iMAT analysis using the average (across participants) log2 481 
transcriptome sample and the human genome-scale metabolic network model, Recon2 59, as input. 482 
Probes targeting transcripts of the same gene were averaged, producing a single mRNA abundance 483 
value for a given gene at a specific sampling time point. Averaged mRNA abundance values were 484 
discretised into three levels (-1, 0, 1) to represent three activity states (inactive, neutral, and active, 485 
respectively) for that sampling time point, using the percentile thresholds of ≤ 20% (state -1), >20% 486 
and ≤ 80% (state 0), and > 80% (state 1). All exchange reactions (reactions that control the 487 
12 
 
uptake/excretion of metabolites) in the Recon2 model were unbounded. Subsequent outputs of Fast 488 
iMAT included the predicted activity state (-1, 0, 1) for each of the 10,770 reactions within the 489 
Recon2 model for each time point. Thus, for each reaction within the metabolic model we obtained 490 
a predicted metabolic activity profile across the circadian cycle. Metabolic reactions for which we 491 
obtained an activity profile exhibiting at least one change in state were further analysed. The fit (R2) 492 
of each metabolic activity profile to a sinusoidal function was assessed and a threshold of R2 ≥ 0.8 493 
was used to identify predicted rhythmic metabolic activity profiles. 494 
 495 
Metabolic reactions identified as rhythmic (predicted metabolic activity profile R2 ≥ 0.8) were 496 
mapped to the genes annotated as responsible for carrying out these reactions in the Recon2 model. 497 
The mapped genes were subsequently mapped to human KEGG pathway maps 60-62 using the R 498 
package PathView 63 for visualisation.  499 
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Figure Legends 683 
 684 
 685 
Figure 1. Circadian expression of the human white adipose tissue transcriptome. 686 
Temporal expression profiles measured in five six-hourly white adipose tissue biopsies collected 687 
from seven participants in constant routine conditions. 688 
(A) Heatmap showing the mixed model values at averaged DLMO times (average per sampling point 689 
across subjects). Red represents high expression, blue low expression. 690 
(B) The average of z-scored mixed model profiles per cluster was calculated. Lines represent the 691 
average profile of all probes within each cluster. 692 
(C) Histogram of peak time estimates of probes identified as exhibiting circadian rhythmicity. Peak 693 
times were derived from the mixed modelling. 694 
(D-E) Representative profiles of probes exhibiting either (D) morning and (E) evening peak 695 
expression. Thin black lines show each participant’s gene expression profile plotted according to 696 
their own DLMO. The red thick line depicts the sinusoidal model fit and the blue thick vertical line 697 
indicates estimated peak time. 698 
 699 
Figure 2. Circadian rhythms of canonical clock genes in human white adipose tissue. 700 
Temporal expression profiles of canonical clock genes measured in five six-hourly white adipose 701 
tissue biopsies collected from seven participants in constant routine conditions. Thin black lines 702 
show each participant’s gene expression profile plotted relative to their own DLMO. The red thick 703 
line depicts the sinusoidal model fit and the blue thick vertical line indicates the estimated peak 704 
time. 705 
 706 
Figure 3. Overlap of Gene Ontology biological process terms associated with rhythmically 707 
expressed genes in human, mouse and baboon. Only terms associated with rhythmic genes for 708 
which there is a homolog in human considered. 709 
 710 
Figure 4. Molecular interaction network associated with morning-peaking genes. 711 
Molecular interaction networks for genes encoding transcripts found to peak during the morning 712 
were computed using the STRING online database. Node size reflects the number of direct 713 
connections a molecule has within the network. Thickness of lines (edges) connecting nodes 714 
represents strength of evidence (confidence) supporting each connection as provided by STRING. 715 
 716 
Figure 5. Predicted rhythmicity of the mitochondrial short-chain, fatty acid elongation pathway. 717 
The activity of metabolic reactions in a metabolic model was assessed using the ‘Fast iMAT’ 718 
algorithm of MUFINS using averaged transcriptome samples and the human metabolic model 719 
Recon2 as input. For each reaction within the metabolic model we obtained a predicted metabolic 720 
activity profile across the circadian cycle. EC numbers represent specific enzymatic reactions. Circles 721 
and boxes indicate metabolites and reactions, respectively. Red boxes indicate reactions that were 722 
identified as rhythmic. Lines next to each circadian reaction indicate the dynamics (high or low) for 723 
each reaction across each of the five biopsy time points.  724 
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Tables 725 
 726 
 727 
Table 1. GO (process) enrichment of human adipose circadian genes 728 
 729 
 730 
  731 
Morning (Cluster 1) 258 probes Evening (Cluster 2 and 3) 579 probes 
Biological Process p-value FDR Biological Process p-value FDR 
Gene expression 3.609E-08 1.023E-04 Single-organism metabolic process 1.846E-18 8.853E-15 
Cellular nitrogen 
compound metabolic 
process 
2.876E-07 4.077E-04 Organonitrogen compound metabolic process 7.917E-15 1.300E-11 
Histone H3 
deacetylation 4.844E-07 4.577E-04 Cofactor metabolic process 8.134E-15 1.300E-11 
RNA metabolic 
process 
1.756E-06 1.245E-03 
Small molecule metabolic 
process 
2.904E-14 3.481E-11 
Nitrogen compound 
metabolic process 3.328E-06 1.887E-03 
Organic acid metabolic 
process 9.592E-14 9.199E-11 
Nucleobase-containing 
compound metabolic 
process 
4.157E-06 1.964E-03 Carboxylic acid metabolic process 5.182E-13 4.141E-10 
Circadian regulation of 
gene expression 5.557E-06 2.251E-03 Oxoacid metabolic process 6.827E-13 4.676E-10 
Cellular metabolic 
process 
7.245E-06 2.568E-03 
Coenzyme metabolic 
process 
2.214E-12 1.327E-09 
Heterocycle metabolic 
process 
1.083E-05 3.411E-03 Single-organism 
biosynthetic process 
8.464E-12 4.509E-09 
Cellular aromatic 
compound metabolic 
process 
1.703E-05 4.613E-03 Oxidation-reduction process 1.589E-10 7.618E-08 
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Table 2. GO (molecular function) enrichment of human adipose circadian transcripts 732 
 733 
Morning cluster (Cluster 1) 258 probes Evening cluster (Cluster 2 and 3)  579 probes 
Molecular Function p-value FDR Molecular Function p-value FDR
Heterocyclic 
compound binding 
3.255E-07 1.327E-04 Catalytic activity 2.554E-12 2.521E-09 
Organic cyclic 
compound binding 5.835E-07 1.327E-04 Oxidoreductase activity 1.826E-09 9.012E-07 
Nucleic acid binding 2.277E-06 3.454E-04 Binding 5.370E-08 1.767E-05 
Transcription 
corepressor binding 4.662E-05 4.315E-03 Protein binding 5.370E-06 1.325E-03 
Transcription cofactor 
binding 4.741E-05 4.315E-03 
Transferase activity, 
transferring alkyl or aryl 
(other than methyl) groups 
9.583E-06 1.892E-03 
Core promoter binding 9.358E-05 7.097E-03 
Oxidoreductase activity, 
acting on the CH-NH group 
of donors, NAD or NADP as 
acceptor 
1.455E-05 2.394E-03 
Binding 3.083E-04 2.004E-02 Lyase activity 2.189E-05 2.802E-03 
RNA binding 5.542E-04 3.011E-02 Electron carrier activity 2.271E-05 2.802E-03 
Ubiquitin binding 6.378E-04 3.011E-02 Aldehyde-lyase activity 7.113E-05 7.800E-03 
Core promoter 
sequence-specific 
DNA binding 
6.617E-04 3.011E-02 Carbon-carbon lyase activity 1.021E-04 1.008E-02 
  734 
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Table 3. Participant demographics 735 
 736 
        
  Physiological Variables Mean ± S.D.   
Age (years) 22.9 ± 3.4  
Body Mass Index (kg/m2) 23.9 ± 2.4  
Body Fat (%) 16.8 ± 6.0 
  Questionnaire Data Mean ± S.D.    
Munich Chronotype 
Sleep Time (decimal hr) 23.21 ± 0.39 
Wake Time (decimal hr) 07.88 ± 0.53 
Horne-Östberg score 50.0 ± 7.8 
Pittsburgh Sleep Quality Index 2.9 ± 1.2 
Beck Depression Inventory 1.0 ± 1.2 
Epworth Sleepiness Scale 5.1 ± 1.3 
  Ethnicity N   
White 6 
  African 1   
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